Irritable Bowel Syndrome Treatment Market
The treatment of irritable bowel syndrome majorly revolves around relieving the patient from the symptoms associated with the condition, as the causes behind occurrence of irritable bowel syndrome are yet unknown. Patients suffering from irritable bowel syndrome show symptoms such as abdominal pain, diarrhea, and constipation. Long-term and recurring presence of these symptoms signals the possibility of irritable bowel syndrome. The treatment depends on severity of these symptoms, which are distinguished as mild, moderate, and severe. Mild symptoms do not significantly affect the quality of life. However, severe symptoms are more frequent and intense and need to be addressed. The disease is often linked with dietary, lifestyle factors, and stress, which can be controlled by managing stress levels, diet, and exercise. Severe symptoms need to be treated through medication prescribed by physicians. Two major therapy options are available for the treatment of IBS, namely, medical or drug therapy and nutritional therapy. Medical therapy includes drugs for relieving the symptoms and nutritional therapy by using fibers and probiotics or prebiotics depending on the situation.
Market Dynamics
The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome (IBS), for which various companies such as Ironwood Pharmaceuticals, Inc., conduct mass workshops for educating the people to incorporate healthy food habits as a major precaution towards prevention of IBS. Moreover, major growth drivers for the irritable bowel syndrome treatment market are expected to launch various pipeline drugs for the treatment of irritable bowel syndrome during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. For instance, according to the data provided by International Foundation for Gastrointestinal Disorders, a non-profit, educational and research organization, it’s estimated that 5-10% of the population has IBS worldwide. According to the same source, stress does not cause IBS. However, because of the connection between the brain and the gut, stress can worsen or trigger the symptoms.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 27 market data tables and 31 figures on "Global Irritable Bowel Syndrome Market” - forecast to 2030
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
